Cravatt Benjamin has filed 5 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 70000 shares of KYNTRA BIO, INC. ($KYNB) on June 05, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2024 | KYNTRA BIO, INC. | $KYNB | Cravatt Benjamin | Not found | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 98,770,000 | 9999.99% | 0.07% |
| June 7, 2023 | KYNTRA BIO, INC. | $KYNB | Cravatt Benjamin | Director | A | Common Stock | 8289 | $0.00 | 32,680.0000 | 0 | 33.98% | 0.00% |
| June 9, 2023 | KYNTRA BIO, INC. | $KYNB | Cravatt Benjamin | Director | S | Common Stock | 1766 | $16.75 | 30,914.0000 | 0 | 5.40% | 0.00% |
| June 9, 2023 | KYNTRA BIO, INC. | $KYNB | Cravatt Benjamin | Director | S | Common Stock | 2178 | $17.51 | 28,736.0000 | 0 | 7.05% | 0.00% |
| June 7, 2023 | KYNTRA BIO, INC. | $KYNB | Cravatt Benjamin | Director | A | Stock Option (Right to Buy) | 12666 | $0.00 | 12,666.0000 | 0 | 9999.99% | 0.00% |